News

Huntington Bank Welcomes Marc Dizard as New Investment Leader

Huntington Bank Welcomes Marc Dizard as New Investment Leader

Huntington Bank Names Marc Dizard as Chief Investment Officer

Dizard's expertise is set to elevate Huntington Wealth Management's investment strategy.

Introducing Marc Dizard's Leadership Role

Huntington National Bank is thrilled to announce the appointment of Marc Dizard as the chief investment officer for Huntington Wealth Management. This change affirms the dedication of Huntington to spearhead innovative investment strategies that are essential for meeting client objectives.

In his new role, Dizard will be accountable for crafting and implementing a modern investment platform that provides tailored advice and generates strong, risk-adjusted returns tailored to various client categories, including the mass affluent, high-net-worth, ultra-high-net-worth, and institutional investors. He will report directly to Aaron Reber, the director of wealth management strategy and solutions.

Dizard's Impressive Background in Investments

Dizard came to Huntington from Market Street Trust Company, where he previously served as chief investment officer. During his tenure, he was instrumental in transforming the investment philosophy and framework of the firm, which specializes in catering to multi-generational family offices. With nearly two decades of experience in finance, he has held pivotal leadership roles at PNC Financial Services, notably as the chief investment strategist for PNC Asset Management, managing investment strategies for an impressive portfolio exceeding $190 billion.

Strong Endorsements from Huntington Leadership

The announcement of Dizard's appointment has been met with praise from Huntington's leadership. Melissa Holding, the director of wealth management, remarked, "Marc brings a proven track record in building successful investment programs that create exceptional outcomes for clients. As we continue to advance our wealth management business, Marc will be crucial in driving our strategic priorities and realizing our investment vision."

Marc Dizard's Academic and Professional Credentials

Dizard's credentials are noteworthy. He holds a Bachelor of Science in Business Administration from The Ohio State University and boasts valuable certifications as a CFA charterholder and a CFP professional. His dedication extends beyond finance; he is also actively engaged in various industry and community organizations. He currently chairs the Board for PreventionFIRST! and serves on the Cincinnati Zoo Foundation Board, reflecting his commitment to community service. His leadership in the finance community includes past board roles with the CFA Society of Cincinnati and ongoing contributions to the Catholic Community Foundation of West Central and Southwest Ohio.

Dizard's Vision for Investment Strategy

Reflecting on his new position, Dizard expressed enthusiasm about joining Huntington. He stated, "Huntington has a legacy of putting people first, and I'm energized by the opportunity to join a talented, disciplined, and growing team connected by a shared vision. My focus will be on enhancing and modernizing our investment platform and capabilities, all in support of helping our clients meet their goals." This commitment illustrates his intent to fortify Huntington's reputation as a leader in the wealth management sector.

Commitment to Excellence in Wealth Management

The appointment of Marc Dizard as chief investment officer underscores Huntington's unwavering commitment to providing world-class investment solutions. This move not only enhances their Wealth Management division but also reinforces Huntington's strategy to drive sustainable growth and value for their esteemed clients.

For individuals eager to learn more about Huntington Wealth Management's comprehensive services and offerings, visiting huntington.com will provide an extensive overview of their investment strategies and financial solutions.

About Huntington

Huntington Bancshares Incorporated is a prominent regional bank holding company managing assets worth approximately $223 billion, centrally based in Columbus. Since its establishment in 1866, The Huntington National Bank has expanded its reach to provide a full spectrum of banking, payments, wealth management, and risk management solutions for consumers, small and middle-market businesses, corporations, municipalities, and various organizations. With a presence across over 1,000 branches in 14 states, Huntington continues to deliver exceptional banking experiences and services to its growing clientele.

Frequently Asked Questions

Who is Marc Dizard?

Marc Dizard is the new chief investment officer for Huntington Wealth Management, responsible for leading investment strategies.

What is Huntington Wealth Management's focus?

Huntington Wealth Management focuses on delivering comprehensive investment solutions to mass affluent and high-net-worth clients.

What are Dizard's qualifications?

Dizard holds a Bachelor of Science in Business Administration and is both a CFA charterholder and a CFP professional.

What was Dizard's previous role?

Before joining Huntington, Dizard served as chief investment officer at Market Street Trust Company.

How does Huntington support community initiatives?

Huntington actively participates in community service, and Dizard serves on multiple boards, reflecting a strong commitment to community engagement.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 35

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 28

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 44

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 24

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 29

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 33

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading

Top 5 Most Recently Viewed Articles

CareDx and Dovetail Genomics Forge New Path in Transplant Solutions

Updated Category News Views 79

Partnership to Enhance HLA Typing Technology CareDx, Inc. (NASDAQ: CDNA), renowned for its pioneering precision medicine approach for transplant patients, has recently joined forces with Dovetail Genomics, a recognized leader in genomic solutions. This notable collaboration is set to introduce an Early Access Program designed for HLA laboratories, leveraging a unique...

Continue Reading
Pet Valu Holdings Secures C$150 Million Through Secondary Offering

Updated Category News Views 285

Pet Valu Holdings Hits Milestone with Recent Secondary Offering MARKHAM, Ontario — Pet Valu Holdings Ltd. (“Pet Valu” or the “Company”) (TSX: PET), a prominent name in Canadian specialty retailing, has unveiled the successful completion of its secondary bought deal offering. This initiative has generated an impressive C$150 million through the sale of 5,200,000...

Continue Reading
SMCP Settles Legal Proceedings Over 15.9% Stake Dispute

Updated Category News Views 116

Overview of SMCP's Recent Legal Developments In a significant update, SMCP has received confirmation regarding the legal proceedings related to a notable 15.9% stake in its share capital. The London Court of Appeal has denied requests from Dynamic Treasure Group (DTG) to appeal the High Court's decision, which ruled the sale of shares to DTG as invalid. This ruling...

Continue Reading
Grit Real Estate Announces Important AGM Details for Shareholders

Updated Category News Views 91

Grit Real Estate Income Group's Upcoming AGM Grit Real Estate Income Group Limited, a pan-African leader in real estate, has made a significant announcement regarding its forthcoming Annual General Meeting (AGM). This event is set to take place on a Friday, specifically at 14h30 Mauritian time. Although the exact location is specified, the company invites all eligible...

Continue Reading
Petaluma Enriches Pet Nutrition with Dr. Sarah Dodd

Updated Category News Views 271

Petaluma Welcomes Dr. Sarah Dodd as Advisor and Formulator Petaluma, a forward-thinking sustainable pet nutrition company, is excited to announce the addition of Dr. Sarah Dodd as an Advisor and Formulator. Dr. Dodd is a renowned figure in the field of plant-based pet nutrition, bringing with her a wealth of experience to transform pet food for a sustainable and humane...

Continue Reading